coupon
Prescription drugWhats That
Composition :
CHLORTHALIDONE-6.25MG
Manufacturer/Marketer :
Ipca Laboratories Ltd
Consume Type :
ORAL
Return Policy :
Not Returnable
Expires on or after :
Secure Payment
Trusted by 8 Crore Indians
Genuine Products
Author Details
Disclaimer
While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
Alcohol
Caution
You are recommended not to consume alcohol along with CTD-6.25 Tablet to avoid unpleasant side-effects.
Pregnancy
Caution
CTD-6.25 Tablet is classified as FDA pregnancy risk category B. So, CTD-6.25 Tablet should not be used during pregnancy unless clearly necessary. Prolonged intake of CTD-6.25 Tablet during pregnancy may cause jaundice (yellowing of skin and eye), unexplained bruising, low blood sugar and electrolyte imbalance in the neonates (newborn baby). Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast Feeding
Caution
CTD-6.25 Tablet should not be used when breastfeeding unless clearly necessary. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Driving
Caution
Driving after taking CTD-6.25 Tablet is not recommended as it may occasionally cause drowsiness.
Liver
Caution
CTD-6.25 Tablet to be taken with caution, especially if you have a history of liver diseases/conditions. The dose may have to be adjusted by your doctor.
Kidney
Caution
CTD-6.25 Tablet to be taken with caution, especially if you have a history of kidney diseases/conditions. Your doctor may adjust your dose depending upon your current kidney conditions.
Children
Caution
CTD-6.25 Tablet to be taken with caution, especially if you are children below the age of 12. Your doctor may adjust your dose depending upon your age.
Product Substitutes
Drug-Drug Interactions
Critical
Drug-Drug Interactions
Login/Sign Up
Critical
How does the drug interact with CTD-6.25 Tablet:
Co-administration of CTD-6.25 Tablet and cisapride may increase the risk or severity of an irregular heart rhythm that may be serious.
How to manage the interaction:
Taking CTD-6.25 Tablet with Cisapride is not recommended, please consult your doctor before taking it. Do not discontinue the medication without consulting a doctor.
Co-administration of CTD-6.25 Tablet and cisapride may increase the risk or severity of an irregular heart rhythm that may be serious.
How to manage the interaction:
Taking CTD-6.25 Tablet with Cisapride is not recommended, please consult your doctor before taking it. Do not discontinue the medication without consulting a doctor.
How does the drug interact with CTD-6.25 Tablet:
Taking CTD-6.25 Tablet can make the body eliminate Arsenic trioxide faster, leading to lower levels in the blood and potentially reducing its effectiveness.
How to manage the interaction:
Co-administration of CTD-6.25 Tablet with Arsenic trioxide can possibly result in an interaction, but it can be taken if a doctor has advised it. If you have any of these symptoms, it's important to contact a doctor right away: your heart beating irregularly, feeling dizzy or lightheaded, fainting, having a fast or pounding heartbeat, feeling weak or drowsy, being confused, experiencing muscle pain, or feeling nauseous or vomiting. Do not discontinue any medications without consulting a doctor.
Taking CTD-6.25 Tablet can make the body eliminate Arsenic trioxide faster, leading to lower levels in the blood and potentially reducing its effectiveness.
How to manage the interaction:
Co-administration of CTD-6.25 Tablet with Arsenic trioxide can possibly result in an interaction, but it can be taken if a doctor has advised it. If you have any of these symptoms, it's important to contact a doctor right away: your heart beating irregularly, feeling dizzy or lightheaded, fainting, having a fast or pounding heartbeat, feeling weak or drowsy, being confused, experiencing muscle pain, or feeling nauseous or vomiting. Do not discontinue any medications without consulting a doctor.
Severe
How does the drug interact with CTD-6.25 Tablet:
Coadministration of CTD-6.25 Tablet with amiodarone may increase the risk of abnormal heart rhythms.
How to manage the interaction:
Although taking CTD-6.25 Tablet with amiodarone may cause an interaction, it is safe to do so if your doctor has prescribed it. If you have a cardiac problem or electrolyte imbalances, you may be more vulnerable. If you develop sudden dizziness, lightheadedness, fainting, shortness of breath, or a rapid heartbeat, consult a doctor. Do not stop taking any medications without visiting a doctor.
Coadministration of CTD-6.25 Tablet with amiodarone may increase the risk of abnormal heart rhythms.
How to manage the interaction:
Although taking CTD-6.25 Tablet with amiodarone may cause an interaction, it is safe to do so if your doctor has prescribed it. If you have a cardiac problem or electrolyte imbalances, you may be more vulnerable. If you develop sudden dizziness, lightheadedness, fainting, shortness of breath, or a rapid heartbeat, consult a doctor. Do not stop taking any medications without visiting a doctor.
How does the drug interact with CTD-6.25 Tablet:
Co-administration of CTD-6.25 Tablet with ziprasidone can increase the risk of an irregular heart rhythm that may be serious.
How to manage the interaction:
Although there is an interaction, CTD-6.25 Tablet can be taken with ziprasidone if prescribed by the doctor. but it can be taken together if prescribed by a doctor. However, consult your doctor if you experience sudden dizziness, lightheadedness, fainting, shortness of breath, weakness, tiredness, drowsiness, confusion, muscle pain, cramps, nausea, or vomiting. Do not discontinue any medications without consulting a doctor.
Co-administration of CTD-6.25 Tablet with ziprasidone can increase the risk of an irregular heart rhythm that may be serious.
How to manage the interaction:
Although there is an interaction, CTD-6.25 Tablet can be taken with ziprasidone if prescribed by the doctor. but it can be taken together if prescribed by a doctor. However, consult your doctor if you experience sudden dizziness, lightheadedness, fainting, shortness of breath, weakness, tiredness, drowsiness, confusion, muscle pain, cramps, nausea, or vomiting. Do not discontinue any medications without consulting a doctor.
Severe
How does the drug interact with CTD-6.25 Tablet:
Co-administration of CTD-6.25 Tablet together with lithium can increase the effects of lithium.
How to manage the interaction:
Although there is a interaction between CTD-6.25 Tablet and lithium, but it can be taken together if prescribed by a doctor. However, consult your doctor if you experience diarrhea, vomiting, drowsiness, shaking of hands and legs, thirst, increased urination, lack of coordination, or muscle weakness. Do not discontinue any medications without consulting a doctor.
Co-administration of CTD-6.25 Tablet together with lithium can increase the effects of lithium.
How to manage the interaction:
Although there is a interaction between CTD-6.25 Tablet and lithium, but it can be taken together if prescribed by a doctor. However, consult your doctor if you experience diarrhea, vomiting, drowsiness, shaking of hands and legs, thirst, increased urination, lack of coordination, or muscle weakness. Do not discontinue any medications without consulting a doctor.
Severe
How does the drug interact with CTD-6.25 Tablet:
Co-administration of Tizanidine and CTD-6.25 Tablet may show additive effects and increase the risk of low blood pressure.
How to manage the interaction:
Although there is an interaction, CTD-6.25 Tablet can be taken with tizanidine if prescribed by the doctor. If you experience headache, dizziness, palpitations, or sweating, contact your doctor immediately. Do not discontinue any medications without consulting a doctor.
Co-administration of Tizanidine and CTD-6.25 Tablet may show additive effects and increase the risk of low blood pressure.
How to manage the interaction:
Although there is an interaction, CTD-6.25 Tablet can be taken with tizanidine if prescribed by the doctor. If you experience headache, dizziness, palpitations, or sweating, contact your doctor immediately. Do not discontinue any medications without consulting a doctor.
chlorthalidoneDroperidol
Severe
How does the drug interact with CTD-6.25 Tablet:
Taking Droperidol can make CTD-6.25 Tablet less effective in lowering blood pressure.
How to manage the interaction:
Taking CTD-6.25 Tablet with Droperidol together can possibly result in an interaction, but it can be taken if your doctor has advised it. If you have any of these symptoms, it's important to contact your doctor right away. These symptoms include an irregular heart rhythm, severe or long-lasting diarrhea or vomiting, complications, sudden dizziness or lightheadedness, fainting, difficulty breathing, heart palpitations, weakness, feeling sleepy or confused, muscle pain, and feeling nauseous or vomiting. Do not stop using any medications without first talking to your doctor.
Taking Droperidol can make CTD-6.25 Tablet less effective in lowering blood pressure.
How to manage the interaction:
Taking CTD-6.25 Tablet with Droperidol together can possibly result in an interaction, but it can be taken if your doctor has advised it. If you have any of these symptoms, it's important to contact your doctor right away. These symptoms include an irregular heart rhythm, severe or long-lasting diarrhea or vomiting, complications, sudden dizziness or lightheadedness, fainting, difficulty breathing, heart palpitations, weakness, feeling sleepy or confused, muscle pain, and feeling nauseous or vomiting. Do not stop using any medications without first talking to your doctor.
chlorthalidoneAminolevulinic acid
Severe
How does the drug interact with CTD-6.25 Tablet:
Co-administration of Aminolevulinic acid and CTD-6.25 Tablet may increase the risk of severe sunburn.
How to manage the interaction:
Taking CTD-6.25 Tablet with Aminolevulinic acid together can possibly result in an interaction, but it can be taken if a doctor has advised it. If you notice that your skin is very sensitive to sunlight or if you have a really bad sunburn, it's important to contact your doctor right away. Do not discontinue any medications without consulting a doctor.
Co-administration of Aminolevulinic acid and CTD-6.25 Tablet may increase the risk of severe sunburn.
How to manage the interaction:
Taking CTD-6.25 Tablet with Aminolevulinic acid together can possibly result in an interaction, but it can be taken if a doctor has advised it. If you notice that your skin is very sensitive to sunlight or if you have a really bad sunburn, it's important to contact your doctor right away. Do not discontinue any medications without consulting a doctor.
Severe
How does the drug interact with CTD-6.25 Tablet:
Co-administration of CTD-6.25 Tablet with pimozide can increase the risk of an irregular heart rhythm that may be serious.
How to manage the interaction:
Although there is an interaction, CTD-6.25 Tablet can be taken with pimozide if prescribed by the doctor. Consult the prescriber if you develop sudden dizziness, lightheadedness, fainting, or fast or pounding heartbeats during treatment with pimozide. Also, let the doctor know if you experience signs of electrolyte disturbance, such as weakness, tiredness, drowsiness, confusion, muscle pain, cramps, dizziness, nausea, or vomiting. Do not discontinue any medications without consulting a doctor.
Co-administration of CTD-6.25 Tablet with pimozide can increase the risk of an irregular heart rhythm that may be serious.
How to manage the interaction:
Although there is an interaction, CTD-6.25 Tablet can be taken with pimozide if prescribed by the doctor. Consult the prescriber if you develop sudden dizziness, lightheadedness, fainting, or fast or pounding heartbeats during treatment with pimozide. Also, let the doctor know if you experience signs of electrolyte disturbance, such as weakness, tiredness, drowsiness, confusion, muscle pain, cramps, dizziness, nausea, or vomiting. Do not discontinue any medications without consulting a doctor.
Drug-Food Interactions
No Drug - Food interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.
Drug-Food Interactions
Login/Sign Up
Drug-Diseases Interactions
CHLORTHALIDONE-6.25MGAnuria and oliguria
Severe
CHLORTHALIDONE-6.25MGAnuria and oliguria
Severe
Drug-Diseases Interactions
Login/Sign Up
CHLORTHALIDONE-6.25MGAnuria and oliguria
Severe
How does the disease interact with CTD-6.25 Tablet:
Thiazide diuretics should not be used in people who have anuria.
How to manage the interaction:
CTD-6.25 Tablet is contraindicated in patients with anuria.
Thiazide diuretics should not be used in people who have anuria.
How to manage the interaction:
CTD-6.25 Tablet is contraindicated in patients with anuria.
CHLORTHALIDONE-6.25MGAnuria and oliguria
Severe
How does the disease interact with CTD-6.25 Tablet:
Thiazide diuretics should not be used in people who have anuria.
How to manage the interaction:
CTD-6.25 Tablet is contraindicated in patients with anuria.
Thiazide diuretics should not be used in people who have anuria.
How to manage the interaction:
CTD-6.25 Tablet is contraindicated in patients with anuria.
CHLORTHALIDONE-6.25MGOther disorders of fluid, electrolyte and acid-base balance
Severe
How does the disease interact with CTD-6.25 Tablet:
Thiazide diuretics are usually associated with electrolyte loss, most notably potassium, but also sodium, chloride, bicarbonate, and magnesium. Other electrolytes, such as phosphate, bromide, and iodide, are normally lost in trace amounts. Potassium and magnesium deficiency can cause arrhythmias and cardiac arrest. Metabolic alkalosis and hyponatremia are two other electrolyte-related disorders that are seldom fatal.
How to manage the interaction:
Therapy with CTD-6.25 Tablet should be administered cautiously in patients with or predisposed to fluid and electrolyte depletion. Fluid and electrolyte abnormalities should be corrected before initiating therapy, and blood pressure and serum electrolyte concentrations should be monitored periodically and maintained at normal ranges during therapy. Consult the doctor if you experience signs and symptoms of fluid or electrolyte imbalance, including dry mouth, thirst, weakness, lethargy, drowsiness, restlessness, muscle pains or cramps, muscular fatigue, hypotension, oliguria, tachycardia, arrhythmia, or gastrointestinal disturbances such as nausea and vomiting.
Thiazide diuretics are usually associated with electrolyte loss, most notably potassium, but also sodium, chloride, bicarbonate, and magnesium. Other electrolytes, such as phosphate, bromide, and iodide, are normally lost in trace amounts. Potassium and magnesium deficiency can cause arrhythmias and cardiac arrest. Metabolic alkalosis and hyponatremia are two other electrolyte-related disorders that are seldom fatal.
How to manage the interaction:
Therapy with CTD-6.25 Tablet should be administered cautiously in patients with or predisposed to fluid and electrolyte depletion. Fluid and electrolyte abnormalities should be corrected before initiating therapy, and blood pressure and serum electrolyte concentrations should be monitored periodically and maintained at normal ranges during therapy. Consult the doctor if you experience signs and symptoms of fluid or electrolyte imbalance, including dry mouth, thirst, weakness, lethargy, drowsiness, restlessness, muscle pains or cramps, muscular fatigue, hypotension, oliguria, tachycardia, arrhythmia, or gastrointestinal disturbances such as nausea and vomiting.
CHLORTHALIDONE-6.25MGOther diseases of liver
Severe
How does the disease interact with CTD-6.25 Tablet:
Thiazide-induced hypokalemic hypochloremic alkalosis is especially dangerous in patients with severe liver disease or cirrhosis. In individuals with already elevated amounts, blood ammonia levels may rise further. Electrolyte changes associated with diuretic usage have resulted in hepatic encephalopathy and mortality. Thiazide diuretic therapy should be used with caution in patients with poor hepatic function or progressive liver disease, and should be stopped immediately if indications of imminent hepatic coma occur (e.g., tremors, disorientation, and increasing jaundice).
How to manage the interaction:
Therapy with CTD-6.25 Tablet should be administered cautiously in patients with impaired liver function or progressive liver disease, and discontinued promptly if signs of impending hepatic coma appear.
Thiazide-induced hypokalemic hypochloremic alkalosis is especially dangerous in patients with severe liver disease or cirrhosis. In individuals with already elevated amounts, blood ammonia levels may rise further. Electrolyte changes associated with diuretic usage have resulted in hepatic encephalopathy and mortality. Thiazide diuretic therapy should be used with caution in patients with poor hepatic function or progressive liver disease, and should be stopped immediately if indications of imminent hepatic coma occur (e.g., tremors, disorientation, and increasing jaundice).
How to manage the interaction:
Therapy with CTD-6.25 Tablet should be administered cautiously in patients with impaired liver function or progressive liver disease, and discontinued promptly if signs of impending hepatic coma appear.
CHLORTHALIDONE-6.25MGSystemic lupus erythematosus
Severe
How does the disease interact with CTD-6.25 Tablet:
Thiazide diuretics have been reported to worsen or activate systemic lupus erythematosus. Chlorothiazide and hydrochlorothiazide have been linked to reported instances. Thiazide diuretics should be used with caution in individuals having a history or risk of SLE.
How to manage the interaction:
The use of CTD-6.25 Tablet has been reported to possibly exacerbate or activate systemic lupus erythematosus (SLE). Therapy with thiazide diuretics should be administered cautiously in patients with a history or risk of SLE.
Thiazide diuretics have been reported to worsen or activate systemic lupus erythematosus. Chlorothiazide and hydrochlorothiazide have been linked to reported instances. Thiazide diuretics should be used with caution in individuals having a history or risk of SLE.
How to manage the interaction:
The use of CTD-6.25 Tablet has been reported to possibly exacerbate or activate systemic lupus erythematosus (SLE). Therapy with thiazide diuretics should be administered cautiously in patients with a history or risk of SLE.
CHLORTHALIDONE-6.25MGOther disorders of kidney and ureter, not elsewhere classified
Severe
How does the disease interact with CTD-6.25 Tablet:
Thiazide diuretics may be ineffective when the glomerular filtration rate (GFR) is low (less than 25 mL/min) because they are not expected to be filtered into the renal tubule, where they work. Furthermore, thiazide diuretics lower GFR and may cause azotemia in patients with renal failure. Because most of these medicines are eliminated unaltered in the urine through glomerular filtration and active tubular secretion, cumulative effects may occur. Thiazide diuretic therapy should be used with caution and at lower doses in individuals with renal impairment. If renal function worsens over time, as shown by increased BUN or serum creatinine levels, thiazide medication should be interrupted or discontinued.
How to manage the interaction:
Therapy with CTD-6.25 Tablet should be administered cautiously at reduced dosages in patients with kidney impairment.
Thiazide diuretics may be ineffective when the glomerular filtration rate (GFR) is low (less than 25 mL/min) because they are not expected to be filtered into the renal tubule, where they work. Furthermore, thiazide diuretics lower GFR and may cause azotemia in patients with renal failure. Because most of these medicines are eliminated unaltered in the urine through glomerular filtration and active tubular secretion, cumulative effects may occur. Thiazide diuretic therapy should be used with caution and at lower doses in individuals with renal impairment. If renal function worsens over time, as shown by increased BUN or serum creatinine levels, thiazide medication should be interrupted or discontinued.
How to manage the interaction:
Therapy with CTD-6.25 Tablet should be administered cautiously at reduced dosages in patients with kidney impairment.
CHLORTHALIDONE-6.25MGAsthma
Moderate
How does the disease interact with CTD-6.25 Tablet:
Thiazide diuretics should be administered with caution in individuals with a history of bronchial asthma because to the possibility of hypersensitive responses.
How to manage the interaction:
CTD-6.25 Tablet should be used with caution in patients with history of bronchial asthma as sensitivity reactions may occur.
Thiazide diuretics should be administered with caution in individuals with a history of bronchial asthma because to the possibility of hypersensitive responses.
How to manage the interaction:
CTD-6.25 Tablet should be used with caution in patients with history of bronchial asthma as sensitivity reactions may occur.
CHLORTHALIDONE-6.25MGUnspecified diabetes mellitus
Moderate
How does the disease interact with CTD-6.25 Tablet:
Thiazide diuretics can induce hyperglycemia and glycosuria in diabetics. They can also cause diabetes in pre-diabetic persons. These symptoms are normally reversible if the medicines are stopped. Thiazide diuretic therapy should be used with caution in individuals with diabetes, glucose intolerance, or a propensity to hyperglycemia. Diabetes mellitus patients should be regularly watched during thiazide medication, and their antidiabetic regimen should be changed accordingly.
How to manage the interaction:
CTD-6.25 Tablet may cause high blood sugar levels and glycosuria (glucose in the urine) in patients with diabetes. Therapy with CTD-6.25 Tablet should be administered cautiously in patients with diabetes mellitus, glucose intolerance, or a predisposition to high blood sugar levels. Patients with diabetes mellitus should be monitored more closely during therapy.
Thiazide diuretics can induce hyperglycemia and glycosuria in diabetics. They can also cause diabetes in pre-diabetic persons. These symptoms are normally reversible if the medicines are stopped. Thiazide diuretic therapy should be used with caution in individuals with diabetes, glucose intolerance, or a propensity to hyperglycemia. Diabetes mellitus patients should be regularly watched during thiazide medication, and their antidiabetic regimen should be changed accordingly.
How to manage the interaction:
CTD-6.25 Tablet may cause high blood sugar levels and glycosuria (glucose in the urine) in patients with diabetes. Therapy with CTD-6.25 Tablet should be administered cautiously in patients with diabetes mellitus, glucose intolerance, or a predisposition to high blood sugar levels. Patients with diabetes mellitus should be monitored more closely during therapy.
CHLORTHALIDONE-6.25MGDisorders of lipoprotein metabolism and other lipidaemias
Moderate
How does the disease interact with CTD-6.25 Tablet:
Thiazide diuretics may raise blood triglyceride and cholesterol levels, particularly LDL and VLDL. It is uncertain if these effects are dose-related and persist throughout chronic treatment. Patients with pre-existing hyperlipidemia may require stricter monitoring during thiazide medication, and their lipid-lowering regimen may need to be adjusted accordingly.
How to manage the interaction:
CTD-6.25 Tablet may increase serum triglyceride and cholesterol levels, primarily low-density lipoprotein and very low-density lipoprotein. Patients with preexisting hyperlipidemia may require closer monitoring during thiazide therapy.
Thiazide diuretics may raise blood triglyceride and cholesterol levels, particularly LDL and VLDL. It is uncertain if these effects are dose-related and persist throughout chronic treatment. Patients with pre-existing hyperlipidemia may require stricter monitoring during thiazide medication, and their lipid-lowering regimen may need to be adjusted accordingly.
How to manage the interaction:
CTD-6.25 Tablet may increase serum triglyceride and cholesterol levels, primarily low-density lipoprotein and very low-density lipoprotein. Patients with preexisting hyperlipidemia may require closer monitoring during thiazide therapy.
CHLORTHALIDONE-6.25MGHyperparathyroidism and other disorders of parathyroid gland
Moderate
How does the disease interact with CTD-6.25 Tablet:
Thiazide diuretics reduce urinary calcium excretion when used on a long-term basis. Prolonged treatment has been associated with pathologic alterations in the parathyroid gland, including hypercalcemia and hypophosphatemia. However, typical hyperparathyroidism consequences such as renal lithiasis, bone resorption, and peptic ulcers have not been observed. Clinicians should be aware of these side effects while prescribing or providing thiazide medication to hyperparathyroid patients. These medications should be stopped before doing parathyroid function testing.
How to manage the interaction:
Caution is advised while using CTD-6.25 Tablet in patients with hyperparathyroidism.
Thiazide diuretics reduce urinary calcium excretion when used on a long-term basis. Prolonged treatment has been associated with pathologic alterations in the parathyroid gland, including hypercalcemia and hypophosphatemia. However, typical hyperparathyroidism consequences such as renal lithiasis, bone resorption, and peptic ulcers have not been observed. Clinicians should be aware of these side effects while prescribing or providing thiazide medication to hyperparathyroid patients. These medications should be stopped before doing parathyroid function testing.
How to manage the interaction:
Caution is advised while using CTD-6.25 Tablet in patients with hyperparathyroidism.
CHLORTHALIDONE-6.25MGDisorders of purine and pyrimidine metabolism
Moderate
How does the disease interact with CTD-6.25 Tablet:
Thiazide diuretics slow the excretion of uric acid. Except in patients with a history of gout or chronic renal failure, hyperuricemia is typically asymptomatic and seldom progresses to clinical gout. Thiazide diuretic therapy should be used with caution in such individuals.
How to manage the interaction:
CTD-6.25 Tablet may decrease the rate of uric acid excretion. Therapy should be administered cautiously in such patients.
Thiazide diuretics slow the excretion of uric acid. Except in patients with a history of gout or chronic renal failure, hyperuricemia is typically asymptomatic and seldom progresses to clinical gout. Thiazide diuretic therapy should be used with caution in such individuals.
How to manage the interaction:
CTD-6.25 Tablet may decrease the rate of uric acid excretion. Therapy should be administered cautiously in such patients.
CHLORTHALIDONE-6.25MGAbnormal results of function studies
Moderate
How does the disease interact with CTD-6.25 Tablet:
Thiazide diuretics may lower serum PBI (protein-bound iodine) levels without causing thyroid problems. When prescribing or providing thiazide medication to patients with thyroid problems, clinicians should be aware of this consequence.
How to manage the interaction:
Thiazide diuretics may decrease serum PBI (protein-bound iodine) levels without associated thyroid disturbance. Inform the prescriber if you have thyroid disorders.
Thiazide diuretics may lower serum PBI (protein-bound iodine) levels without causing thyroid problems. When prescribing or providing thiazide medication to patients with thyroid problems, clinicians should be aware of this consequence.
How to manage the interaction:
Thiazide diuretics may decrease serum PBI (protein-bound iodine) levels without associated thyroid disturbance. Inform the prescriber if you have thyroid disorders.
Have a query?
Customers Also Bought
